Correlation Between Novo Nordisk and Bonus BioGroup

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Novo Nordisk and Bonus BioGroup at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novo Nordisk and Bonus BioGroup into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novo Nordisk AS and Bonus BioGroup, you can compare the effects of market volatilities on Novo Nordisk and Bonus BioGroup and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novo Nordisk with a short position of Bonus BioGroup. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novo Nordisk and Bonus BioGroup.

Diversification Opportunities for Novo Nordisk and Bonus BioGroup

0.84
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Novo and Bonus is 0.84. Overlapping area represents the amount of risk that can be diversified away by holding Novo Nordisk AS and Bonus BioGroup in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bonus BioGroup and Novo Nordisk is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novo Nordisk AS are associated (or correlated) with Bonus BioGroup. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bonus BioGroup has no effect on the direction of Novo Nordisk i.e., Novo Nordisk and Bonus BioGroup go up and down completely randomly.

Pair Corralation between Novo Nordisk and Bonus BioGroup

Considering the 90-day investment horizon Novo Nordisk is expected to generate 76.17 times less return on investment than Bonus BioGroup. But when comparing it to its historical volatility, Novo Nordisk AS is 45.12 times less risky than Bonus BioGroup. It trades about 0.05 of its potential returns per unit of risk. Bonus BioGroup is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  4.00  in Bonus BioGroup on September 12, 2024 and sell it today you would lose (2.00) from holding Bonus BioGroup or give up 50.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy99.72%
ValuesDaily Returns

Novo Nordisk AS  vs.  Bonus BioGroup

 Performance 
       Timeline  
Novo Nordisk AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Novo Nordisk AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Bonus BioGroup 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bonus BioGroup has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Novo Nordisk and Bonus BioGroup Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Novo Nordisk and Bonus BioGroup

The main advantage of trading using opposite Novo Nordisk and Bonus BioGroup positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novo Nordisk position performs unexpectedly, Bonus BioGroup can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bonus BioGroup will offset losses from the drop in Bonus BioGroup's long position.
The idea behind Novo Nordisk AS and Bonus BioGroup pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Complementary Tools

Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm